License and Development Agreements (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2023	Jan. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue				$ 3,699	$ 485	$ 443	$ 466	$ 643	$ 500	$ 928	$ 1,143	$ 4,627	$ 1,609	$ 6,036	$ 2,488
Expense incurred				7,048	14,574	10,172	17,937	11,602	9,393	24,746	20,995	31,794	38,932	39,573	56,159
NIAID Project NextGen clinical trial initiative	$ 5,000,000
Initial license issuance fee			$ 1,000
Payment annual development and commercial milestones		$ 37,000
Cancellation period, notice		90 days
Collaborative Arrangements
Disaggregation of Revenue [Line Items]
Total revenue				$ 3,699	$ 485	$ 443	$ 466	$ 643	$ 500	$ 928	$ 1,143	$ 4,627	$ 1,609	6,036	2,488
Expense incurred														5,300	9,100
Contract liability														$ 10,525	$ 11,221